Subject: Concerns Regarding a
CIRCARE is concerned about clinical trials at several sites in the US and Canada in which participants diagnosed with severe psychiatric disorders were treated with an investigational drug lacking approval from the FDA, or its Canadian counterpart, Health Canada. Our concerns, based on information in the public record, are:
We thank the Schizophrenia Society of Ontario and consumer watchdog Dr. Terry Polevoy for bringing this matter to our attention, and we will provide updates as more information becomes available.
Elizabeth Woeckner MA, CIRCARE Board of Directors
Michael A. Susko MS, CIRCARE President
Nutraceutical Treatment of Mental Disorders in Adults: An RCT with Bipolar Disorderand
Fibromyalgia Clinical Study.2002-01-04. Available from http://www.circare.org/FOIA/hc_cta_20020104.pdf
Link: To create an HTML link to this InfoMail cut and paste the following:
<a href="http://www.circare.org/im/im27June2002.htm">Concerns Regarding a
Nutritional Cure</a>. CIRCARE InfoMail (2002-06-27)
Last Updated: 2006-02-26
If you find the information on this page helpful please support CIRCARE with a tax-deductible contribution today. Help us advocate for meaningful protection of human subjects in research. Donating on-line with PayPal is quick and easy. Find out more on our Support page.
All material on this site © CIRCARE Incorporated (2002- ) or as indicated. Single copies can be downloaded for personal education. Adobe Reader™ :: ::